EOLS

Handel nachbörslich: 10.89

Evolus Inc (EOLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1176)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EOLS's Discussions on Twitter

Vergleichen Sie EOLS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EOLS Evolus Inc	10.89	689.57M	202.09M	-61.69M	-35.64M	-1.08
ZTS Zoetis Inc	164.84	74.37B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.09	25.03B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.52	14.94B	15.05B	-883.30M	1.89B	-0.74

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2022-06-23	Eingeleitet	Needham	Buy
2022-05-12	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-20	Hochstufung	Truist	Hold → Buy
2021-05-06	Hochstufung	Mizuho	Neutral → Buy
2021-04-08	Bestätigt	H.C. Wainwright	Buy
2021-02-24	Herabstufung	Truist	Buy → Hold
2020-07-07	Herabstufung	Mizuho	Buy → Neutral
2020-02-06	Fortgesetzt	Mizuho	Buy
2019-11-26	Eingeleitet	SVB Leerink	Outperform
2019-09-05	Fortgesetzt	Mizuho	Buy
2019-06-28	Eingeleitet	Wells Fargo	Market Perform
2019-06-11	Eingeleitet	Barclays	Underweight
2019-03-20	Eingeleitet	SunTrust	Buy
2019-02-14	Eingeleitet	H.C. Wainwright	Buy
2019-01-29	Eingeleitet	Stifel	Buy

Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Finanzdaten der Evolus Inc-Aktie (EOLS)

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Vergleichen Sie EOLS mit anderen Aktien

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability - Yahoo Finance

Lord Abbett & CO. LLC Acquires 188,685 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Stock Options Galore! Discover Evolus’ Latest Move - Jomfruland.net

(EOLS) On The My Stocks Page - Stock Traders Daily

Evolus Expands Team with Strategic Equity Incentives Package for 20 New Hires - StockTitan

Evolus's SWOT analysis: aesthetics firm's stock poised for growth By Investing.com - Investing.com South Africa

Evolus's SWOT analysis: aesthetics firm's stock poised for growth - Investing.com

Charles Schwab Investment Management Inc. Buys 265,635 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Evolus, Inc. (NASDAQ:EOLS) Is Expected To Breakeven In The Near Future - Simply Wall St

212,209 Shares in Evolus, Inc. (NASDAQ:EOLS) Acquired by Walleye Capital LLC - MarketBeat

Connor Clark & Lunn Investment Management Ltd. Takes $940,000 Position in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Great Point Partners LLC Has $18.95 Million Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat

Jeffrey Plumer: Defending a ‘Whole New World’ - Orange County Business Journal

When (EOLS) Moves Investors should Listen - Stock Traders Daily

Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher - MSN

Evolus, Inc. (NASDAQ:EOLS) Short Interest Up 8.8% in October - MarketBeat

OC500 2024: Sandra Beaver - Orange County Business Journal

Behind the Bell: Evolus - Nasdaq

Perceptive Advisors LLC Adjusts Stake in Evolus Inc - GuruFocus.com

Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) - Yahoo Finance

Stonepine Capital Management Reduces Stake in Evolus Inc - GuruFocus.com

Evolus, Inc. (NASDAQ:EOLS) Might Not Be As Mispriced As It Looks After Plunging 26% - Simply Wall St

Evolus, Inc. (NASDAQ:EOLS) Position Increased by GSA Capital Partners LLP - MarketBeat

Evolus Inc (EOLS) Shares Gap Down to $12.58 on Nov 12 - GuruFocus.com

Evolus Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates - MSN

Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance

Evolus, Inc. (NASDAQ:EOLS) Q3 2024 Earnings Call Transcript - Insider Monkey

Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges By GuruFocus - Investing.com Canada

Evolus (NASDAQ:EOLS) Shares Gap Down on Disappointing Earnings - MarketBeat

Evolus' (EOLS) Buy Rating Reiterated at HC Wainwright - MarketBeat

Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges - GuruFocus.com

Evolus earnings missed by $0.18, revenue fell short of estimates - Investing.com Canada

Evolus, Inc. Reports Strong Q3 2024 Growth - TipRanks

Evolus Reports Third Quarter 2024 Results - Business Wire

Injections For Your Frown Lines Cost Just $49, Thanks To This Membership Club - The Zoe Report

Prescription Hair Loss and Hair Removal Drugs Market Projected To Witness Substantial Growth, 2024-2031: - EIN News

Evolus receives nod from EU for hyaluronic acid injectables, anticipates US approval - Healio

Evolus (NASDAQ:EOLS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Evolus to Participate in Stifel 2024 Healthcare Conference - The Bakersfield Californian

Evolus, Inc. (NASDAQ:EOLS) Shares Purchased by Rice Hall James & Associates LLC - MarketBeat

Objective long/short (EOLS) Report - Stock Traders Daily

Evolus, Inc. Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels Under New Medical Device Regulation - Marketscreener.com

Evolus Gets EU Approval for Treatment of Wrinkles - MarketWatch

Evolus gains EU certification for new dermal filler products - Investing.com

Evolus gains EU certification for new dermal filler products By Investing.com - Investing.com UK

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EOLS